CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Lebanon, PA
Wellspan Good Samaritan Hospital 252 S. 4th St 4th and Walnut St, Lebanon, PA, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.